Abstract
Using a novel approach, including affinity chromatography, reversed-phase chromatography, and chemiluminescence immunoblotting, we have for the first time been able to demonstrate one of the small synaptic vesicle proteins, synaptotagmin I, in cerebrospinal fluid (CSF). Two other small synaptic vesicle proteins, rab3a and synaptophysin, were not detectable. The approximate molecular weight of CSF-synaptotagmin was 65 kDa, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Further characterization of CSF synaptotagmin by high-performance capillary electrophoresis (HPCE) showed a single peak. These findings support that the whole synaptotagmin molecule is present in CSF, without significant proteolytic degradation. After high-speed centrifugation of CSF, synaptotagmin was exclusively found in the supernatant, suggesting that synaptotagmin is present in CSF as a free protein, and not as a constituent of synaptic vesicles. In a preliminary study, we found a marked reduction of CSF synaptotagmin in patients with early onset Alzheimer disease (EAD) as compared with age-matched healthy individuals. To elucidate the biological relevance of this finding, we also quantified synaptotagmin in brain tissue. A marked reduction in synaptotagmin was found both in the hippocampus and frontal cortex of EAD, suggesting that a decrease in synaptotagmin in the brain is followed by a concomitant decrease in the CSF. Analysis of CSF synaptotagmin might provide a tool to study synaptic function and pathology in the human brain.
Similar content being viewed by others
References
Adolfsson R., Gottfries C. G., Nystrom L., and Winblad B. (1981) Prevalence of dementia in institutionalised Swedish old people: the work load imposed by caring for these patients.Acta Psychiat. Scand. 63, 225–244.
Åkesson B. and Björk L. (1986) A physiochemical study of protein G, a molecule with unique immunoglobulin G binding properties.J. Biol. Chem. 261, 10240–10247.
Alafuzoff I., Iqbal K., Friden H., Adolfsson R., and Winblad B. (1987) Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis.Acta Neuropathol. (Berl.) 74, 209–225.
American Psychiatric Association (APA) (1987)Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., rev. American Psychiatric Association, Washington, DC.
Blennow K. and Wallin A. (1992) Clinical heterogeneity of probable Alzheimer's disease.J. Geriatr. Psychiat. Neurol. 5, 106–113.
Blennow K., Wallin A., and Gottfries C. G. (1991) Presence of parietal lobe symptomatology distinguishes early and late onset Alzheimer's disease.Int. J. Geriatr. Psychiat. 6, 147–154.
Blennow K., Fredman P., Wallin A., Gottfries C. G., Langström L., and Svennerholm L. (1993a) Protein analyses in cerebrospinal fluid: I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio.Eur. Neurol. 33, 126–128.
Blennow K., Fredman P., Wallin A., Gottfries C. G., Karlsson I., Langström L., Skoog I., Svennerholm L., and Wikkelso C. (1993b) Protein analysis in cerebrospinal fluid: II. Reference values derived from healthy individuals 18–88 years in age.Eur. Neurol. 33, 129–133.
Blennow K., Davidsson P., Wallin A., and Ekman R. (1995) Chromogranin A in cerebrospinal fluid: a biochemical market for synaptic degeneration in Alzheimer's disease?Dementia 6, 306–311.
Brose N., Petrenko A. G., Sudhof T. C., and Jahn R. (1992) Synaptotagmin: a Ca++ sensor on the synaptic vesicle surface.Science 256, 1021–1025.
Constantinidis J. (1978) Is Alzheimer's disease a major form of senile dementia? Clinical, Anatomical and genetic data, in:Alzheimer's disease: Senile Dementia and Related Disorders. Aging vol. 7. (Katzman R., Terry R. D., and Bick K. L., eds.) Raven, New York, pp. 15–25.
Davidsson P., Blennow K., and Ekman R. (1995) The barrier-independent form of transthyretin is decreased in CSF of patients with early-onset Alzheimer's disease (submitted).
Davies C. A., Mann D. M. A., Sumpter P. Q., and Yates P. O. (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease.J. Neurol. Sci. 78, 151–164.
DeKosky S. T. and Scheff S. W. (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.Ann. Neurol. 27, 457–464.
Hamos J. E., DeGennaro L. J., and Drachman D. A. (1989) Synaptic loss Alzheimer's disease and other dementias.Neurology 39, 355–361.
Hansen L. A., DeTeresa R., Davies P., and Terry R. D. (1988) Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease.Neurology 38, 48–54.
Hubbard B. M., and Anderson J. M. (1985) Age related variations in the neuron content of the cerebral cortex in senile dementia of Alzheimer type.Neuropathol. Appl. Neurobiol. 11, 369–382.
Jahn R., Schiebler W., Quimet C., Greengard P. A. (1985) A 38,000 dalton membrane protein (p38) present in synaptic vesicles.Proc. Natl. Acad. Sci. USA 82, 4137–4141.
Jessel T. M. and Kandel E. R. (1993) Synaptic transmission: a bidirectional and self-modifiable form of cell-cell communication.Cell/Neuron 72/10 (Suppl.), 1–30.
Katzman R. (1986) Alzheimer's disease.New Engl. J. Med. 314, 964–973.
Kelly R. B. (1993) Storage and release of neurotransmitters.Cell/Neuron 72/10 (Suppl.), 43–53.
Laemmli U. K. (1972) Cleavage of structural proteins during the assembly of the head of bacteriophage.Nature 227, 680–685.
Laemmli U. K. (1972) Cleavage of structural proteins during the assembly of the head of bacteriophage.Nature 227, 680–685.
Lassman H., Weiler R., Fischer P., Bancher C., Jellinger K., Floor E., Danielczyk W., Seitelberger F., and Winkler H. (1992) Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles.Neuroscience 46, 1–8.
Lauter H. (1970) Über Spätformen der Alzheimerschen Krankheit und ihre Beziehung zur senilen Demenz.Psychiatr. Clin. 3, 169–189.
Lauter H. and Meyer J. E. (1968) Clinical and nosological concepts of senile dementia, inSenile Dementia: Clinical and Therapeutic Aspects (Müller C. and Ciompi L., eds.), Huber, Bern, pp. 13–26.
Leary J. J., Brigati D. J., and Ward D. C. (1983) Rapid and sensitive colorimetric method for visualising biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellose.Proc. Natl. Acad. Sci. USA 80, 4045–4049.
Mann D. M. A., Yates P. O., and Marcyniuk B. (1985) Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age.J. Neurol. Sci. 69, 139–159.
Masliah E., Terry R. D., DeTeresa R., and Hansen L. A. (1989) Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer's disease.Neurosci. Lett. 103, 234–239.
Masliah E., Terry R. D., Alford M., DeTeresa R., and Hansen L. A. (1991a) Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.Am. J. Pathol. 138, 235–246.
Masliah E., Hansen L., Albright T., Mallory M., and Terry R. D. (1991b) Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease.Acta Neuropathol. 81, 428–433.
Mason D. Y. and Taylor C. R. (1978) Distribution of transferrin, ferritin and lactoferrin in human tissues.J. Clin. Pathol. 31, 316–327.
Matteoli M., Maimann C., Torri-Tarelli F., Polak J. M., Ceccarelli B., and DeCamilli P. (1988) Differential effect of alpha latrotoxin on exocytosis from small synaptic vesicles and from large dense core vesicles containing calcitonin gene-related peptide at the frog neuromuscular junction.Proc. Natl. Acad. Sci. USA 85, 7366–7370.
Matthew W. D., Tsavaler L., and Reichardt L. F. (1981) Identification of a synaptic vesicle-specific Membrane protein with a wide distribution in neuronal and neurosecretory tissue.J. Cell Biol. 91, 257–269.
McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadian E. M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease.Neurology 34, 939–944.
Neher E. and Penner R. (1994) Mice sans synaptotagmin.Nature 372, 316–317.
Perin M. S., Fried V. A., Mignery G. A., Jahn R., and Südhof T. C. (1990) Phospholipid binding by a synaptic vesicle protein homologous to the regulatory region of protein kinase C.Nature 345, 260–263.
Perin M. S., Johnston P. A., Özcelik T., Jahn R., Francke U., and Südhof T. C. (1991) Structural and functional conservation of synaptotagmin (p65) in drosophilia and humans.J. Biol. Chem. 226, 615–622.
Roth M. (1980) Perspectives in the scientific study of mental illness in old age, inPriorities in Psychiatric Research (Lader M., ed.), John Wiley, Chichester, pp. 91–114.
Roth M. (1986) The association of clinical and neurological findings and its bearing on the classification and aetiology of Alzheimer's disease.Br. Med. Bull. 42, 42–50.
Scheltens P., Barkhof F., Valk J., Algra P. R., van der Hoop R. G., Nauta J., Wolters E. C. (1992) White matter lesions on magnetic resonance imaging in Alzheimer's disease: evidence for heterogeneity.Brain 115, 735–748.
Smith P. K., Krohn R. I., Hermansson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., and Klenk D. C. (1985) Measurement of protein using bicinchoninic acid.Anal. Biochem. 150, 76–85.
Solé M., Munoz-Gómez J., and Campistol J. M. (1990) Role of amyloid in dialysis-related arthropathies, a morphological analysis of 23 cases.Virch. Arch. 417, 523–528.
Südhof T. and Jahn R. (1991) Proteins of synaptic vesicles involved in exocytosis and membrane recycling.Neuron 6, 665–677.
Südhof T. C., DeCamilli P., Niemann H., and Jahn R. (1993) Membrane fusion machinery: insights from synaptic proteins.Cell 75, 1–4.
Suresh U. R., Wilkes S., and Hasleton P. S. (1991) Prealbumin in the diagnosis of bronchopulmonary carcinoid tumours.J. Clin. Pathol. 44, 573–575.
Svennerholm L., and Gottfries C. G. (1994) Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in earlyonset form (type I) and demyelination in late-onset form (type II).J. Neurochem. 62, 1039–1047.
Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A., and Katzman R. (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.Ann. Neurol. 30, 572–580.
Thompson E. J. (1988)The CSF Proteins: A Biomedical Approach. Elsevier, Amsterdam, pp. 67–85.
Tomlinson B. E. and Henderson G. (1976) Some quantitative cerebral findings in normal and demented old people, inNeurobiology of Aging (Terry R. D. and Gershon S., eds.), Raven, New York, pp. 183–204.
Travis J. and Pahnell R. (1973) Selective removal of albumin from plasma by affinity chromatography.Clin. Chim. Acta 49, 49–52.
Zhan S. S., Beyreuther K., and Schmitt H. P. (1993) Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neurophil in various neurodegenerative disorders with dementia.Dementia 4, 66–74.
Zucker-Franklin D., Warfel A., Grysky G., Frangione B., and Teitel D. (1987) Novel monocyte-like properties of microglial/astroglial cells, constitutive secretion of lysozyme and cystatin C.Lab. Invest. 57, 176–185.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davidsson, P., Jahn, R., Bergquist, J. et al. Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid. Molecular and Chemical Neuropathology 27, 195–210 (1996). https://doi.org/10.1007/BF02815094
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02815094